20 results
PRE 14A
QNCX
Quince Therapeutics Inc
4 Apr 23
Preliminary proxy
4:33pm
Governance Guidelines that set forth expectations for directors, director independence standards, board committee structure and functions and other … Independent Director. We believe this new leadership structure reinforces the independence of our board of directors in its oversight of the business
8-K
EX-3.2
4jwhizjp qc9jlill7
1 Aug 22
Quince Therapeutics Details Strategic Growth Plan with Launch of New Corporate Name
9:17am
8-K
EX-10.1
tzgeyhc3so 38
23 Dec 21
Entry into a Material Definitive Agreement
5:26pm
DEF 14A
ela jglhz
22 Apr 20
Definitive proxy
3:26pm
10-K
1ycn0 ndf5m0akgmwo
16 Mar 20
Annual report
4:16pm
8-K
EX-3.2
3177jt6
13 May 19
Cortexyme, Inc. Announces Pricing of Initial Public Offering
5:01pm
424B4
i4qlsc2qtaknvrdj4h6x
9 May 19
Prospectus supplement with pricing info
5:14pm
S-1/A
suzi3e0j3grr 9v
16 Apr 19
IPO registration (amended)
6:04am
S-1
6h1zssj hjb6l7acsqv5
12 Apr 19
IPO registration
5:20pm
DRS
qr5h 9q4sb5b1zd5x
4 Mar 19
Draft registration statement
12:00am
- Prev
- 1
- Next